semaglutide shortage news november 2025 Despite FDA ruling, compounded GLP-1s are still giving Novo and Lilly headaches on the market Despite FDA ruling, compounded GLP-1s

Our latest blog explores the connection between GLP-1s and iron deficiency anemia, including: What recent studies are revealing How to monitor for signs of anemia Nutrition strategies to support healthy iron levels Stay informed and advocate for your blood health

High purity and quality assured

In real-world settings multiple factors contribute to non-persistence, including adverse effects, high cost-sharing and weight loss not meeting patients' expectations.

Bald knnten Stoffe auf den Markt kommen, die noch strker wirken.

sin pasos complicados

In this study we investigated the target occupancy of the dual agonist SAR425899 at the GLP1R in pancreas and GCGR in liver by Positron Emission Tomography/Computed Tomography (PET/CT)